Breaking News

Enteris BioPharma Completes Expansion of Manufacturing Facility

Also launches CDMO business for the development and manufacture of difficult to formulate drugs and highly potent compounds.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enteris BioPharma, a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation, has expanded its Boonton, NJ manufacturing facility and at the same time launched its contract development and manufacturing organization (CDMO) business segment.   Enteris’ capabilities include providing custom solutions for the formulation, development and manufacturing of solid oral doses for difficult to form...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters